BioSIM 抗人 IgE/IGHE 抗体 (利戈组单抗)，

BioSIM 抗人 IgE/IGHE 抗体 (利戈组单抗)，生物类似药，科研用途

产品概述

BioSIM anti-Human IgE/IGHE Antibody (Ligelizumab Biosimilar) 是一种高质量的科研级生物类似抗体，专为免疫学研究设计。该抗体作为利戈组单抗的生物类似药，具有与原研药物相似的分子结构和功能特性，为研究人员提供了经济高效的实验解决方案。

产品详情

• 产品名称：BioSIM anti-Human IgE/IGHE Antibody (Ligelizumab Biosimilar), Research Grade
• 产品货号：SIM0503-5mg
• 产品规格：5mg
• CAS号：1322627-61-1
• 产品类型：二抗
• 供应商：InvivoCrown
• 来源宿主：人源化 (Humanized)
• 反应性：人源 (Human)

产品特点

该利戈组单抗生物类似抗体采用先进的生产工艺制造，具有以下显著特点：

• 在无动物成分的设施中生产，确保实验结果的稳定性和可重复性
• 采用体外无蛋白细胞培养技术，减少潜在的外源污染物干扰
• 经过多步骤纯化过程，包括Protein A或G色谱工艺，确保高纯度
• 人源化设计，降低免疫原性，提高实验特异性

研究领域与应用

该抗体在多种研究领域具有重要应用价值：

• 主要研究领域：荨麻疹发病机制研究及相关药物开发
• 应用类型：
  • ELISA (酶联免疫吸附测定)
  • FACS (流式细胞术)
  • 功能性实验 (Functional assay)
  • 体内研究 (Research in vivo)

储存建议

为确保抗体活性和稳定性，请遵循以下储存条件：

• 避免反复冻融，以防止抗体蛋白降解
• 短期保存(1-2周)： 4°C
• 中期保存(最长12个月)： -20°C
• 长期保存： -80°C

免疫原信息

该BioSIM抗人IgE/IGHE抗体的免疫原性详情请参考产品说明书。对于体内研究应用，建议评估潜在的免疫原性影响。

科研价值

作为利戈组单抗的生物类似药，该抗体为研究人员提供了宝贵的工具，用于探索IgE介导的免疫反应机制，特别是在荨麻疹等过敏性疾病的研究中。其高特异性和稳定性使其成为多种免疫学实验的理想选择。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM anti-Human IgE/IGHE Antibody (Ligelizumab Biosimilar), Research Use

Product Overview

BioSIM anti-Human IgE/IGHE Antibody (Ligelizumab Biosimilar) is a high-quality research-grade biosimilar antibody designed specifically for immunological research. As a biosimilar to Ligelizumab, this antibody possesses similar molecular structure and functional characteristics to the reference drug, providing researchers with a cost-effective experimental solution.

Product Details

• Product Name: BioSIM anti-Human IgE/IGHE Antibody (Ligelizumab Biosimilar), Research Grade
• Product Catalog No.: SIM0503-5mg
• Product Size: 5mg
• CAS Number: 1322627-61-1
• Product Type: Secondary Antibody
• Supplier: InvivoCrown
• Host: Humanized
• Reactivity: Human

Product Features

This Ligelizumab biosimilar antibody is manufactured using advanced production processes and has the following significant features:

• Produced in animal-component-free facilities to ensure experimental stability and reproducibility
• Utilizes protein-free in vitro cell culture technology to reduce potential interference from exogenous contaminants
• Undergoes multi-step purification process, including Protein A or G chromatography, ensuring high purity
• Humanized design to reduce immunogenicity and enhance experimental specificity

Research Fields and Applications

This antibody has important application value in various research fields:

• Primary Research Field: Urticaria pathogenesis research and related drug development
• Application Types:
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • FACS (Flow Cytometry)
  • Functional assay
  • Research in vivo

Storage Recommendations

To ensure antibody activity and stability, please follow the following storage conditions:

• Avoid repeated freeze-thaw cycles to prevent antibody protein degradation
• Short-term storage (1-2 weeks): 4°C
• Medium-term storage (up to 12 months): -20°C
• Long-term storage: -80°C

Immunogenicity Information

Please refer to the product manual for detailed immunogenicity information of this BioSIM anti-Human IgE/IGHE antibody. For in vivo research applications, it is recommended to evaluate potential immunogenicity effects.

Research Value

As a biosimilar of Ligelizumab, this antibody provides researchers with a valuable tool for exploring IgE-mediated immune response mechanisms, especially in the study of allergic diseases such as urticaria. Its high specificity and stability make it an ideal choice for various immunological experiments.

Note: The above information may change due to factors such as product optimization and upgrades. For specific information, please consult Yacoin Biotechnology.